The Royal Wolverhampton NHS Trust

West Midlands, Cancer Alliance

Management of High Grade Dysplasia patients

Time period: 2015-19
Cancer Alliance National
Number of High Grade Dysplasia patients in audit 95 1448
Cancer Alliance National
Method of Diagnosis
– First diagnosis confirmed by second pathologist 88 92.9% 86.9%
Treatment planning
– HGD plan discussed at MDT 83 87.4% 87.9%
– Treatment plan for active treatment 72 75.8% 81.1%
First treatment
– Endoscopic therapy (such as endoscopic resection) 63 65.9% 73.8%
– Surveillance 18 18.7% 11.0%

Management of oesophago-gastric cancer patients

Time period: 2017-2019
Organisation National
Number of oesophago-gastric (OG) cancer patients in audit 161 20528
Case ascertainment for OG cancer (%) 75-84%
Method of Diagnosis
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations
14 8.4% 13.3%
– Patients with referral source reported as unknown 0 0.0% 1.8%
Pre-treatment staging of cancer
– Patients having staging CT scan recorded 35 21.7% 86.9%
Treatment planning
– Patients having a plan for curative treatment 74 46.0% 38.5%
– Patients having a plan for non-curative treatment 87 54.0% 61.5%
– Patients with non-curative plans having chemotherapy or radiotherapy 52 59.8% 48.2%

Download this data as a PDF